Editorial & Columns Spin-off by Pharmaceutical Companies in India: Improved Focus and Valuation July 11, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Expectations from Banking & Economy Front July 6, 2024 | Satish Singh | No Comments | More
Editorial & Columns Competitive Intelligence in Pharmaceutical Industry July 6, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns Action needed as heatwave hurts industry growth July 6, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Modi’s Dilemma Ends : Skips SCO Summit, India’ Reluctance to Replace Dollar by Yuan Is Indicated July 1, 2024 | Gopal Misra | No Comments | More
Editorial & Columns The Emergency’s haunting legacy and path forward June 29, 2024 | Abdul Wasey | No Comments | More
Editorial & Columns Parliament Impasse Amid Paper Leaks June 27, 2024 | Narvijay Yadav | No Comments | More
Editorial & Columns Valuation Premium: India-listed Subsidiaries of Pharma and Healthcare MNCs Outshine Parent firms June 26, 2024 | Dr. Anil Kumar Angrish | No Comments | More
Editorial & Columns G-7 finally moves toward inclusivity and relevance June 22, 2024 | Abdul Wasey | No Comments | More